Peter Wild
Peter Wild
Full Professor of Pathology, Director Dr. Senckenberg Institute of Pathology, Univ. Hospital
Verified email at - Homepage
Cited by
Cited by
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
CE Barbieri, SC Baca, MS Lawrence, F Demichelis, M Blattner, ...
Nature genetics 44 (6), 685-689, 2012
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
C Giesen, HAO Wang, D Schapiro, N Zivanovic, A Jacobs, B Hattendorf, ...
Nature methods 11 (4), 417-422, 2014
WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer
C Wissmann, PJ Wild, S Kaiser, S Roepcke, R Stoehr, M Woenckhaus, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003
Automated Gleason grading of prostate cancer tissue microarrays via deep learning
E Arvaniti, KS Fricker, M Moret, N Rupp, T Hermanns, C Fankhauser, ...
Scientific reports 8 (1), 12054, 2018
Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation
E Holler, G Rogler, H Herfarth, J Brenmoehl, PJ Wild, J Hahn, G Eissner, ...
Blood 104 (3), 889-894, 2004
Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
DN Church, E Stelloo, RA Nout, N Valtcheva, J Depreeuw, N Ter Haar, ...
Journal of the National Cancer Institute 107 (1), dju402, 2015
Reliable detection of subclonal single-nucleotide variants in tumour cell populations
M Gerstung, C Beisel, M Rechsteiner, P Wild, P Schraml, H Moch, ...
Nature communications 3 (1), 811, 2012
Exploring the 3D molecular architecture of Escherichia coli type 1 pili
E Hahn, P Wild, U Hermanns, P Sebbel, R Glockshuber, M Häner, ...
Journal of molecular biology 323 (5), 845-857, 2002
Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis
A Hamm, J Veeck, N Bektas, PJ Wild, A Hartmann, U Heindrichs, ...
BMC cancer 8, 1-15, 2008
Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
X Dai, W Gan, X Li, S Wang, W Zhang, L Huang, S Liu, Q Zhong, J Guo, ...
Nature medicine 23 (9), 1063-1071, 2017
Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma
R Massoumi, S Kuphal, C Hellerbrand, B Haas, P Wild, T Spruss, A Pfeifer, ...
Journal of Experimental Medicine 206 (1), 221-232, 2009
TRIM24 is an oncogenic transcriptional activator in prostate cancer
AC Groner, L Cato, J de Tribolet-Hardy, T Bernasocchi, H Janouskova, ...
Cancer cell 29 (6), 846-858, 2016
Serotonin promotes tumor growth in human hepatocellular cancer
C Soll, JH Jang, MO Riener, W Moritz, PJ Wild, R Graf, PA Clavien
Hepatology 51 (4), 1244-1254, 2010
Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer
JPP Theurillat, ND Udeshi, WJ Errington, T Svinkina, SC Baca, M Pop, ...
Science 346 (6205), 85-89, 2014
Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas
MO Riener, F Stenner, H Liewen, C Soll, S Breitenstein, BC Pestalozzi, ...
Hepatology 49 (5), 1602-1609, 2009
Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer
I Cima, R Schiess, P Wild, M Kaelin, P Schüffler, V Lange, P Picotti, ...
Proceedings of the National Academy of Sciences 108 (8), 3342-3347, 2011
Prediction of progression of non–muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study
M Burger, MNM van der Aa, JMM van Oers, A Brinkmann, ...
European urology 54 (4), 835-844, 2008
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors
E Klopocki, G Kristiansen, PJ Wild, I Klaman, E Castanos-Velez, G Singer, ...
International journal of oncology 25 (3), 641-649, 2004
Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases
B Becker, G Multhoff, B Farkas, PJ Wild, M Landthaler, W Stolz, T Vogt
Experimental dermatology 13 (1), 27-32, 2004
Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A–induced angiogenesis
F Roudnicky, C Poyet, P Wild, S Krampitz, F Negrini, R Huggenberger, ...
Cancer research 73 (3), 1097-1106, 2013
The system can't perform the operation now. Try again later.
Articles 1–20